Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Guide or handbook | 2024
About PWUD, Barriers and enablers, Cannabis, Crime, Equity, Harm reduction, Housing, Illegal drugs, Injecting drugs, Legal system/law enforcement, Mental health, Opioids, Overdose, Poverty, Sex/Gender , Stimulants, Workplace
Guide or handbook | 2024
Advocacy, Drug checking, Harm reduction, Illegal drugs, Injecting drugs, Overdose, Peer/PWLLE program involvement, SCS/OPS, Social services, Wrap-around services
This paper reviews what is known about the effects of opioid use disorder on decision-making, and argues that some subset of these refusals are non-autonomous choices
Commentary | 2023
About PWUD, Legal system/law enforcement, Mental health, Overdose
This report summarizes the first year of operations of two Overdose Prevention Centers (OPC) in NYC.
Report | 2024
Harm reduction, Illegal drugs, Injecting drugs, Mortality, Overdose, SCS/OPS, Social benefits, Social services
This study aims to understand the effects of—and responses to—a changing drug supply among people who use drugs in Rhode Island.
Original research | 2024
About PWUD, Illegal drugs, Injecting drugs, Overdose, Withdrawal
This qualitative study aims to explore patients’ experiences of long-acting injectable depot buprenorphine treatment, including how it feels within the body, experiences of dosing cycles across tim
Original research | 2024
About PWUD, Barriers and enablers, Illegal drugs, Stigma, Substitution/OAT, Withdrawal
This study identified the types of publicly available data used to surveil state-level drug overdoses and characterized these efforts based on their timeliness, drug
Letter | 2023
Hospitals, Illegal drugs, Mortality, Outcomes, Overdose
This study is based on an evaluation of a safer supply program (SSP) in a medium-sized urban centre with a large catchment area that includes rural and Indigenous communities.
Original research | 2024
About PWUD, Barriers and enablers, Equity, Indigenous, Safer supply, Small/medium cities
We aimed to determine the extent to which uptake and discontinuation of an initial attempt at a prescribed safer supply (PSS) program were influenced through networks of prescribers.
Original research | 2024
About prescribers, Hesitancy of prescribers , Evidence base, Outcomes, Policy/Regulatory, Safer supply, Transitions in care/treatment, Workplace
The aim of this submission is to clarify the research and statistics behind injection-related infections among individuals on safer opioid supply (SOS)--daily dispensed immediate-release hydromorph
Letter | 2024
About PWUD, Advocacy, Evidence base, Hospitals, Injecting drugs, Opioids, Safer supply
Essay | 2024
About PWUD, Barriers and enablers, Diversion, Evidence base, Hesitancy of prescribers , Legal system/law enforcement, Overdose, Policy/Regulatory, Safer supply, Stigma, Youth
We examined the number and characteristics of high-volume buprenorphine prescribers and the nature of their buprenorphine prescribing from 2009 to 2018.
Original research | 2024
About prescribers, Substitution/OAT
Canadian Opioid Agonist Therapy (OAT) guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical judgement to decide whether an individual is ‘clinically stable’ to r
Lit review | 2024
About PWUD, Barriers and enablers, Carries/take-home doses, Equity, Hesitancy of prescribers , Stigma, Substitution/OAT, Transitions in care/treatment, Treatment/recovery
Article | 2024
Harm reduction, Illegal drugs, Mortality, Overdose, Safer supply, SCS/OPS
Essay | 2024
Advocacy, Crime, Decriminalization/legalization, Equity, Harm reduction, Illegal drugs, Indigenous, Legal system/law enforcement, Peer/PWLLE program involvement, Stigma
Guidelines | 2021
About prescribers, Alcohol, Benzodiazepines, Cannabis, Chronic pain, Clinical guidance, Harm reduction, Mental health, Opioids, Substitution/OAT, Transitions in care/treatment, Withdrawal
To identify individual and initial prescription-related factors associated with an increased risk for opioid-related misuse, poisoning and dependence (MPD) in patients with non-cancer pain.
Original research | 2024
Chronic pain, Mortality, Opioids, Outcomes, Overdose, Sex/Gender , Transitions in care/treatment
We compared prescription opioid pain medication dispensing for patients with schizophrenia (SZ) or bipolar disorder (BD) versus controls over 5 years, to assess opioid dispensing trends and comorbi
Original research | 2024
Chronic pain, Mental health, Opioids, Social benefits
Lit review | 2024
Cannabis, Harm reduction, Opioids, Policy/Regulatory
